CBD Global Sciences Reports Q3 2019 Results with Revenue of $1.79 million up over 1,000% from Q3 2018 Revenue of $144,000
Denver, CO – December 5, 2019 – CBD Global Sciences, Inc. (CSE: CBDN) (Frankfurt:GS3), “CBD Global” or the “Company”), today announced the release of financial and operational results for the third quarter ended September 30, 2019. These filings are available for review on the Company’s SEDAR profile at www.sedar.com. All amounts are expressed in U.S. […]
CBD Global Sciences Achieves Listing on The Frankfurt Stock Exchange
Denver, CO – November 25, 2019 – CBD Global Sciences, Inc. (CSE: CBDN) (“CBD Global” or the “Company”), today announced that its common shares have been listed on the Frankfurt Stock Exchange under the symbol “GS3.” The Company’s common shares continue to be listed on the Canadian Securities Exchange under the symbol “CBDN.” Brad […]
CBD Global Sciences Announces Expansion of Aethics Hydration Product Line
Denver, CO – November 19, 2019 – CBD Global Sciences, Inc. (CSE: CBDN) (“CBD Global” or the “Company”) is pleased to announce the expansion of its Aethics Hydration product line, launching an all new lineup comprised of infused CBD Balance Sparkling Water in 3 flavors – Grapefruit, Berry, and Lemon Lime. With today’s launch of the […]
